Covered recipient · General Payments record
THANG TRAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,382.17
- Reported across 212 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,296.22 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $621.24 | 19 |
| IBSA Pharma Inc. | $451.32 | 12 |
| Acerta Pharma LLC | $124.99 | 1 |
| Gilead Sciences, Inc. | $73.68 | 3 |
| GlaxoSmithKline, LLC. | $24.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.30 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239906 | CMS |
| ABBVIE INC. | $7.82 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239908 | CMS |
| ABBVIE INC. | $20.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239910 | CMS |
| ABBVIE INC. | $4.80 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239912 | CMS |
| ABBVIE INC. | $59.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239914 | CMS |
| ABBVIE INC. | $19.83 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239916 | CMS |
| ABBVIE INC. | $10.35 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239918 | CMS |
| ABBVIE INC. | $14.03 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239920 | CMS |
| ABBVIE INC. | $8.85 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239922 | CMS |
| ABBVIE INC. | $21.67 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239924 | CMS |
| ABBVIE INC. | $12.45 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239926 | CMS |
| ABBVIE INC. | $10.14 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239928 | CMS |
| ABBVIE INC. | $146.54 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239930 | CMS |
| ABBVIE INC. | $29.99 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239932 | CMS |
| ABBVIE INC. | $26.08 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239934 | CMS |
| ABBVIE INC. | $125.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239936 | CMS |
| ABBVIE INC. | $26.00 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239938 | CMS |
| ABBVIE INC. | $19.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239940 | CMS |
| ABBVIE INC. | $31.70 | 12/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106239942 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105405350 | CMS |
| Gilead Sciences, Inc. | $27.48 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768811 | CMS |
| Gilead Sciences, Inc. | $23.30 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768813 | CMS |
| Gilead Sciences, Inc. | $22.90 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133768815 | CMS |
| GlaxoSmithKline, LLC. | $24.99 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116223286 | CMS |
| IBSA Pharma Inc. | $18.16 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984028 | CMS |
| IBSA Pharma Inc. | $125.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142976880 | CMS |
| IBSA Pharma Inc. | $24.86 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984030 | CMS |
| IBSA Pharma Inc. | $22.41 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984032 | CMS |
| IBSA Pharma Inc. | $16.17 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984034 | CMS |
| IBSA Pharma Inc. | $23.29 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984036 | CMS |
| IBSA Pharma Inc. | $19.13 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984038 | CMS |
| IBSA Pharma Inc. | $125.00 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977152 | CMS |
| IBSA Pharma Inc. | $20.02 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974019 | CMS |
| IBSA Pharma Inc. | $21.39 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974021 | CMS |
| IBSA Pharma Inc. | $18.70 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975014 | CMS |
| IBSA Pharma Inc. | $17.19 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975727 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.